문의해 주셔서 감사합니다.
contact.you.lab.product.request.text
(Business Unit Performance Materials, Sales Support Team)
Gedung AIA Central, Level 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesia
+62 21 2988 8557
성공! 귀하의 문의가 영업팀에 제출되었습니다.
pim.add.to.wishlist.popup.error
개의 제품을 찾았습니다
| 요청자의 연락처 세부 정보 | |
| Full name | |
| Company | |
| Position | |
| Telephone number | |
| Work email address | |
| Shipping address | |
Thank you. Your request has been sent.
Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.
Products still subject to third-party patent protection might be available solely for R&D purposes.
Refarmed Chemicals proudly presents Carbocisteine Lysine salt monohydrate, a meticulously crafted mucolytic agent essential for healthcare professionals treating patients with respiratory tract disorders. This fine, white to slightly yellow powder exhibits high-quality performance, designed to alleviate conditions like chronic bronchitis, COPD, pneumonia, and cystic fibrosis through its ability to degrade thick, viscous mucus, facilitating easier expectoration and promoting respiratory comfort. Formulated for oral administration as a soluble powder, Carbocisteine Lysine salt monohydrate ensures convenient dosing flexibility. Each sachet contains a precisely calibrated amount of the active ingredient, offering consistent therapeutic efficacy. The typical adult dosage is 750 mg thrice daily, with adjustments made to accommodate individual patient needs by healthcare providers. Quality assurance is at the heart of our corporate ethos. This product conforms to stringent standards, with every batch undergoing rigorous testing to confirm solubility, identification, pH balance, and purity. Our assay guarantees a potency range of 98.0% - 101.0%, ensuring that each dose delivers the expected therapeutic effect. Furthermore, the product's compliance with heavy metal regulations and the meticulous control of residual solvents like ethanol underline our commitment to safety. Moreover, Carbocisteine Lysine salt monohydrate accommodates a broad spectrum of patients, with sensible precautions established for those with a history of gastrointestinal issues or hypersensitivity to its constituents. This product should be used under medical supervision, especially for those with liver or kidney impairments, or during pregnancy and lactation. It is contraindicated in individuals with active peptic ulcers. Storage is straightforward—simply keep the product in a cool, dry environment below 25°C, away from light and moisture, to maintain its integrity. Available in various package sizes, this pharmaceutical offers adaptability for different clinical settings and patient requirements. Choose Carbocisteine Lysine salt monohydrate for dependable respiratory support, backed by the trusted name of Refarmed Chemicals, a company aspiring towards delivering growth in Asia and beyond.
Products still subject to third-party patent protection might be available solely for R&D purposes.
Refarmed Chemicals presents Emedastine Difumarate, an exemplary antihistamine pharmaceutical agent meticulously designed to grant symptomatic relief for individuals battling allergic conjunctivitis. As a testament to its efficacy, Emedastine Difumarate operates as a selective blocker of histamine H1 receptors, adeptly preventing the histamine-induced dilation of blood vessels and curbing mast cell degranulation. Crafted as an ophthalmic solution, the medicine should be administered with precision—1 drop into each affected eye, twice daily—to ensure optimal results. The product is characterized by its white to yellowish powder form, testament to its purity and the high standards of manufacturing. Typically soluble in water and sparsely soluble in anhydrous ethanol, the product maintains a clean and uncolored appearance in the solution with a pH range carefully maintained between 3.0 to 4.5. In compliance with rigorous industry standards, Emedastine Difumarate proudly bears EU GMP certification, guaranteeing its production under the highest quality management protocols. Furthermore, it is crucial to note that the product is strictly contraindicated for individuals with known hypersensitivity to its components and should be avoided by those with narrow-angle glaucoma. Utilization of Emedastine Difumarate may lead to temporary blurred vision and other minor visual disturbances; hence, caution is advised while engaging in tasks necessitating sharp vision post-application. Moreover, it's celebrated for its well-tolerated nature, with minimal side effects, predominantly confined to the ocular region such as itching or burning sensations, and less commonly systemic effects like headache or fatigue. Our product ensures a safe storage parameter within room temperature (20-25°C) and gives due attention to light protection, thereby maintaining its integrity. With Emedastine Difumarate, Refarmed Chemicals delivers an established, profound solution for alleviation from the discomfort caused by allergic conjunctivitis, steering toward better ocular health for patients worldwide.
Products still subject to third-party patent protection might be available solely for R&D purposes.
**Product Overview: Febuxostat – A Robust Solution for Gout Management** Refarmed Chemicals presents Febuxostat, a meticulously prepared medication aimed at alleviating the pain and discomfort associated with gout. Made from a refined white powder, Febuxostat stands out in the pharmaceutical industry as a Xanthine Oxidase Inhibitor, crucial for managing hyperuricemia and recurrent gout attacks. Structured to meet corporate expectations, Febuxostat is a testament to Refarmed Chemicals' 30-year expertise in delivering quality generic and branded medications. Manufactured in compliance with strict guidelines, including the Drug Master File (DMF) and certifications such as WC and GMP, this product is a model of reliability and efficacy. Febuxostat's fundamental use is to decrease blood uric acid levels, offering those afflicted with gout a pathway to recovery by preventing acute flare-ups, and mitigating inflammation and pain in the joints. As a white, soluble powder, Febuxostat is highly soluble in DMSO and slightly soluble in methanol and water, simplifying its integration into diverse medical formulations. Clinical trials have informed a standard starting dosage of 40 mg, adjustable up to 80 mg based on individual patient requirements and the severity of symptoms. In its commitment to patient welfare, Refarmed Chemicals underlines potential side effects ranging from nausea and headaches to rashes, ensuring informed usage of Febuxostat. In alignment with our promise of transparency and safety, we advise consulting healthcare professionals for precise diagnotics and treatment plans. Furthermore, users should be attentive to contraindications, noting that Febuxostat is unsuitable for patients with severe liver or kidney disease, or for women who are pregnant or breastfeeding. Refarmed Chemicals' Febuxostat exceeds industry standards with its impressive assay value of 98.0% - 102.0% purity and a precise control of impurities, ensuring that the product meets stringent quality criteria. The company's analytical rigor is reflected in the detailed specification of residual solvents such as Acetone, Ethanol, and Isopropanol. In the journey to deliver improved health outcomes, Refarmed Chemicals' Febuxostat is more than just a medication; it symbolizes our dedication to quality, safety, and corporate responsibility in the global pharmaceutical landscape. [*Note: Product image depicts a detailed specification chart for Febuxostat, reiterating its quality and compositions.*]
Products still subject to third-party patent protection might be available solely for R&D purposes.